Princeton University holds vaccination event against meningitis B

Princeton University announced it began a second immunization event against meningitis B on Monday to maintain control over a potential meningitis outbreak on campus.

The University recently notified the U.S. Centers for Disease Control and Prevention and New Jersey Department of Health of eight cases of serogroup B meningococcal disease on campus. Princeton was advised against cancelling campus events or activities due to the meningitis infections, but took action by initiating an immunization campaign against the bacterial infection to prevent a potential outbreak.

The first immunization campaign was held between December 9 and 12 and was successful in administering the first dose of meningitis B vaccine to 5,268 individuals, which represented approximately 91 percent of the campus population eligible for vaccination.

The university is asking that all persons who received the first dose of the meningitis B vaccine return for the second dose, since two doses are needed for full immunity against infection.

University experts recommend that members of the community mind their personal hygiene practices and sharing of bodily fluids at this time as a way to protect against infection. All persons who develop a high fever should seek medical attention immediately.